158 related articles for article (PubMed ID: 15283149)
1. [Gefitinib in non-small cell lung cancer].
Nakagawa K
Nihon Rinsho; 2004 Jul; 62(7):1312-20. PubMed ID: 15283149
[No Abstract] [Full Text] [Related]
2. Gefitinib. Still no convincing results in non-small cell lung cancer.
Prescrire Int; 2010 Jun; 19(107):113. PubMed ID: 20738034
[No Abstract] [Full Text] [Related]
3. Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
Bearz A; Fratino L; Spazzapan S; Berretta M; Giacalone A; Simonelli C; Tirelli U
Lung Cancer; 2007 Jan; 55(1):125-7. PubMed ID: 17064811
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.
Wang MZ; Li LY; Wang SL; Zhang XT; Zhong W; Zhang L
Chin Med J (Engl); 2006 Jan; 119(1):63-8. PubMed ID: 16454984
[No Abstract] [Full Text] [Related]
5. The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer.
Comis RL
Oncologist; 2005 Aug; 10(7):467-70. PubMed ID: 16079313
[No Abstract] [Full Text] [Related]
6. Biomarkers of response to gefitinib in non-small-cell lung cancer.
Carbone DP
Nat Clin Pract Oncol; 2004 Dec; 1(2):66-7. PubMed ID: 16264818
[No Abstract] [Full Text] [Related]
7. Gefitinib does not increase survival in lung cancer patients.
Golsteyn RM
Drug Discov Today; 2005 Mar; 10(6):381. PubMed ID: 15808815
[No Abstract] [Full Text] [Related]
8. APL during gefitinib treatment for non-small-cell lung cancer.
Uchida A; Matsuo K; Tanimoto M
N Engl J Med; 2005 Feb; 352(8):843. PubMed ID: 15728826
[No Abstract] [Full Text] [Related]
9. Improvements in quality of life and disease-related symptoms in patients with advanced non-small cell lung cancer treated with gefitinib.
Zhang XT; Li LY; Wang SL; Mu XL; Wang MZ; Song W
Chin Med J (Engl); 2005 Oct; 118(19):1661-4. PubMed ID: 16232354
[No Abstract] [Full Text] [Related]
10. Gefitinib in patients with non-small cell lung cancer: symptomatic improvement within a few days.
Bearz A; Vaccher E; Spazzapan S; Berretta M; Tirelli U
Lung Cancer; 2005 Sep; 49(3):417-8. PubMed ID: 16102608
[No Abstract] [Full Text] [Related]
11. Implications of the Iressa Survival Evaluation in Lung Cancer trial and the future of gefitinib.
Belani CP; Ramalingam S
Clin Lung Cancer; 2005 Jan; 6(4):203-4. PubMed ID: 15694010
[No Abstract] [Full Text] [Related]
12. Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer.
Viswanathan A; Pillot G; Govindan R
Lung Cancer; 2005 Dec; 50(3):417-8. PubMed ID: 16129510
[No Abstract] [Full Text] [Related]
13. Gefitinib.
Muhsin M; Graham J; Kirkpatrick P
Nat Rev Drug Discov; 2003 Jul; 2(7):515-6. PubMed ID: 12841190
[No Abstract] [Full Text] [Related]
14. Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.
Shao YY; Lin CC; Yang CH
Discov Med; 2010 Jun; 9(49):538-45. PubMed ID: 20587343
[TBL] [Abstract][Full Text] [Related]
15. New drug to treat most common lung cancer.
FDA Consum; 2005; 39(1):3. PubMed ID: 15818792
[No Abstract] [Full Text] [Related]
16. [Erlotinib. A new option for non-small cell lung cancer].
Polk B
Med Monatsschr Pharm; 2006 Jan; 29(1):4-6. PubMed ID: 16463547
[No Abstract] [Full Text] [Related]
17. Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.
Cho D; Kocher O; Lee JC; Tenen DG; Meyerson ML; Janne PA; Halmos B
J Clin Oncol; 2005 Jan; 23(1):235-7. PubMed ID: 15625379
[No Abstract] [Full Text] [Related]
18. Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: results from a prospective feasibility study.
Hotta K; Inoue A; Kiura K; Ueoka H; Nukiwa T; Tanimoto M
Lung Cancer; 2005 Dec; 50(3):413-5. PubMed ID: 16154232
[No Abstract] [Full Text] [Related]
19. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
Bunn PA
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5919-20. PubMed ID: 17062660
[No Abstract] [Full Text] [Related]
20. [Analysis of therapeutic efficacy in 49 patients with advanced non-small cell cancer treated with gefitinib].
Zhang PL; Chen L
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):635-6. PubMed ID: 18210890
[No Abstract] [Full Text] [Related]
[Next] [New Search]